Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Impact of adjuvant chemotherapy on outcomes in appendiceal cancer
Bhaskar C. Kolla
, Ashley Petersen
, Madhuri Chengappa
, Tulasi Gummadi
, Chitra Ganesan
,
Wolfgang B. Gaertner
,
Anne Blaes
Surgery
Cancer Prevention and Control
Research output
:
Contribution to journal
›
Article
›
peer-review
34
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Impact of adjuvant chemotherapy on outcomes in appendiceal cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adjuvant Chemotherapy
100%
Appendiceal Cancer
100%
Secondary Cytoreductive Surgery
62%
Well-differentiated
50%
Appendiceal Adenocarcinoma
50%
Overall Survival
37%
Cytoreductive Surgery
25%
Tumor Patients
25%
Cancer Patients
12%
Tumor
12%
Capecitabine
12%
5-fluorouracil (5-FU)
12%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
12%
Oxaliplatin
12%
Significant Predictors
12%
Cox Proportional Hazards Model
12%
Tumor Subtype
12%
Tumor Grade
12%
Log-rank Test
12%
Median Overall Survival
12%
Kaplan-Meier Plot
12%
Differential Survival
12%
Capecitabine Plus Oxaliplatin
12%
Relapse-free Survival
12%
Retrospective Medical Record Review
12%
Statistically Significant Difference
12%
Tumor Histopathology
12%
Medicine and Dentistry
Malignant Neoplasm
100%
Adjuvant Chemotherapy
100%
Neoplasm
50%
Adenocarcinoma
50%
Overall Survival
50%
Capecitabine
12%
Medical Record
12%
Histopathology
12%
Proportional Hazards Model
12%
Log Rank Test
12%
Recurrence Free Survival
12%
Cytoreductive Surgery
12%
Oxaliplatin
12%
Tumor
12%
Hyperthermic Intraperitoneal Chemotherapy
12%
Capecitabine Plus Oxaliplatin
12%